Peijia Medical Executive and Leadership Team

Michael Zhang, the Chairman & Chief Executive Officer at Peijia Medical, directs the overarching corporate strategy and global operations. Zhang guides the company's mission to deliver innovative medical products, particularly in structural heart disease and neurovascular interventions. This leadership involves setting the vision for product development, market expansion, and ensuring the company's commitment to patient well-being. Michael Zhang oversees the integration of research, manufacturing, and commercialization efforts to meet the evolving needs of hospitals and healthcare providers worldwide. The Chairman & Chief Executive Officer ensures alignment with regulatory standards and drives the company's financial performance and long-term growth objectives. This executive role is central to Peijia Medical's position as a global provider of high-end medical devices.

Leo Tsai, the Chief Financial Officer at Peijia Medical, manages all financial aspects of the global organization. Tsai oversees financial planning, budgeting, forecasting, and reporting to ensure fiscal health and strategic resource allocation. This leadership role involves managing capital investments, investor relations, and securing funding to support the company's ambitious growth initiatives in high-end medical devices. Leo Tsai works in tandem with the Chairman & Chief Executive Officer to align financial strategies with the company's mission of improving patient outcomes in cardiovascular and neurovascular treatments. The Chief Financial Officer's oversight extends to risk management and ensuring compliance with international financial regulations. By optimizing financial operations, Tsai directly contributes to Peijia Medical's ability to deliver safe, effective, and accessible healthcare solutions.

Karl Pan, the Chief Operating Officer at Peijia Medical, directs the company's global manufacturing, supply chain, and operational efficiency. Pan ensures the seamless production of innovative medical devices, including those for structural heart disease and neurovascular interventions, meeting stringent quality and safety standards. This role involves optimizing production processes and managing logistics to ensure timely delivery of products to hospitals and healthcare providers worldwide. Karl Pan collaborates with the Chief Technology Officer to scale new technologies from development to mass production. The Chief Operating Officer's focus is on enhancing operational performance, reducing costs, and maintaining the integrity of the supply chain. By driving operational excellence, Karl Pan supports Peijia Medical's commitment to providing accessible and effective solutions that improve patient quality of life.

JianFong Tan, the Chief Technology Officer at Peijia Medical, architects the technological roadmap and drives innovation across all product lines. Tan leads the research and development teams focused on creating advanced medical devices for structural heart disease and neurovascular interventions. This involves overseeing the design, engineering, and testing of new technologies to ensure safety, efficacy, and accessibility. JianFong Tan collaborates closely with the Chief Operating Officer to translate technological advancements into scalable manufacturing processes. The Chief Technology Officer's responsibilities include staying abreast of emerging scientific discoveries and market trends to maintain Peijia Medical's competitive edge. By fostering a culture of continuous improvement, Tan ensures the development of solutions that significantly enhance patient quality of life.